Posted On: 12/12/2013 2:08:12 PM
Post# of 144840

$CTIC Up to date company activities and other important information about $CTIC
$CTIC
DD Notes ~ http://www.ddnotesmaker.com/CTIC
##### recent news/filings ~ source: finance.yahoo.com
Thu, 12 Dec 2013 18:24:22 GMT ~ Most active Nasdaq-traded stocks
read full: http://sg.finance.yahoo.com/news/most-active-...nance.html
*********************************************************
Tue, 10 Dec 2013 23:04:00 GMT ~ 3:44 am Cell Therapeutics presents interim results from Phase 2 Tosedostat Trial in older patients with acute myeloid leukemia or myelodysplastic syndrome
- 3:44 am Cell Therapeutics presents interim results from Phase 2 Tosedostat Trial in older patients with acute myeloid leukemia or myelodysplastic syndrome
read full: http://finance.yahoo.com/news/inplay-briefing....html#ctic
*********************************************************
Tue, 10 Dec 2013 14:20:12 GMT ~ Keep an Eye on Geron, Novartis, Cell Therapeutics, and Verastem Today
- Geron, Novartis, Cell Therapeutics, and Verastem could make health care headlines this morning. Here’s why.
read full: http://www.fool.com/investing/general/2013/12...lnk0000001
*********************************************************
Tue, 10 Dec 2013 14:06:07 GMT ~ Preliminary Findings of BrainStorm's Phase IIa Study Reported as "Extremely Optimistic"
- NEW YORK & PETACH TIKVAH, Israel - December 10, 2013 - BrainStorm Cell Therapeutics (OTCQB: BCLI) a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced that ...
read full: http://www.noodls.com/view/790223A45097BE3D65...DED745779F
*********************************************************
Tue, 10 Dec 2013 08:56:55 GMT ~ Cell Therapeutics Announces Presentation of Interim Results from Phase 2 Tosedostat Trial in Older Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) at ASH Annual Meeting
- SEATTLE, Dec. 10, 2013 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced promising interim results from an investigator-initiated Phase 2 clinical trial of tosedostat ...
read full: http://www.noodls.com/view/A6A53D3FDB783FBBB1...5E760DA6BA
*********************************************************
##### chart ~ source: stockcharts.com
stockcharts.com/c-sc/sc?s=CTIC&p=D&b=5&g=0&id=p95448242713
##### chart ~ source: eoddata.com
http://chart.eoddata.com/?e=OTCBB&s=CTIC&...D&b=BB
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/CTIC/company-info
Ticker: $CTIC
OTC Market Place: Not Available
CIK code: 0000891293
Company name: Cell Therapeutics, Inc.
Company website: http://www.cticseattle.com
Incorporated In: WA, USA
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/CTIC/filings
Latest financials: http://www.otcmarkets.com/stock/CTIC/financials
Latest news: http://www.otcmarkets.com/stock/CTIC/news - http://finance.yahoo.com/q/h?s=CTIC+Headlines
Major holdings: http://data.cnbc.com/quotes/CTIC/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=CTIC+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/CTIC.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=CTIC
RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search
DTCC: http://search2.dtcc.com/?q=Cell+Therapeutics%...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...ics%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://www.cticseattle.com
Alexa: http://www.alexa.com/siteinfo/http://www.cticseattle.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.cticseattle.com
http://www.pennystocktweets.com/stocks/profile/CTIC
##### last known share structure ~ source: otcmarkets.com
Market Value: $235,080,391 a/o Dec 11, 2013
Shares Outstanding: 129,878,669 a/o Oct 25, 2013
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
##### business description ~ source: otcmarkets.com
DD Notes ~ http://www.ddnotesmaker.com/CTIC
$CTIC
DD Notes ~ http://www.ddnotesmaker.com/CTIC
##### recent news/filings ~ source: finance.yahoo.com
Thu, 12 Dec 2013 18:24:22 GMT ~ Most active Nasdaq-traded stocks
read full: http://sg.finance.yahoo.com/news/most-active-...nance.html
*********************************************************
Tue, 10 Dec 2013 23:04:00 GMT ~ 3:44 am Cell Therapeutics presents interim results from Phase 2 Tosedostat Trial in older patients with acute myeloid leukemia or myelodysplastic syndrome
- 3:44 am Cell Therapeutics presents interim results from Phase 2 Tosedostat Trial in older patients with acute myeloid leukemia or myelodysplastic syndrome
read full: http://finance.yahoo.com/news/inplay-briefing....html#ctic
*********************************************************
Tue, 10 Dec 2013 14:20:12 GMT ~ Keep an Eye on Geron, Novartis, Cell Therapeutics, and Verastem Today
- Geron, Novartis, Cell Therapeutics, and Verastem could make health care headlines this morning. Here’s why.
read full: http://www.fool.com/investing/general/2013/12...lnk0000001
*********************************************************
Tue, 10 Dec 2013 14:06:07 GMT ~ Preliminary Findings of BrainStorm's Phase IIa Study Reported as "Extremely Optimistic"
- NEW YORK & PETACH TIKVAH, Israel - December 10, 2013 - BrainStorm Cell Therapeutics (OTCQB: BCLI) a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced that ...
read full: http://www.noodls.com/view/790223A45097BE3D65...DED745779F
*********************************************************
Tue, 10 Dec 2013 08:56:55 GMT ~ Cell Therapeutics Announces Presentation of Interim Results from Phase 2 Tosedostat Trial in Older Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) at ASH Annual Meeting
- SEATTLE, Dec. 10, 2013 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced promising interim results from an investigator-initiated Phase 2 clinical trial of tosedostat ...
read full: http://www.noodls.com/view/A6A53D3FDB783FBBB1...5E760DA6BA
*********************************************************
##### chart ~ source: stockcharts.com
stockcharts.com/c-sc/sc?s=CTIC&p=D&b=5&g=0&id=p95448242713
##### chart ~ source: eoddata.com
http://chart.eoddata.com/?e=OTCBB&s=CTIC&...D&b=BB
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/CTIC/company-info
Ticker: $CTIC
OTC Market Place: Not Available
CIK code: 0000891293
Company name: Cell Therapeutics, Inc.
Company website: http://www.cticseattle.com
Incorporated In: WA, USA
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/CTIC/filings
Latest financials: http://www.otcmarkets.com/stock/CTIC/financials
Latest news: http://www.otcmarkets.com/stock/CTIC/news - http://finance.yahoo.com/q/h?s=CTIC+Headlines
Major holdings: http://data.cnbc.com/quotes/CTIC/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=CTIC+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/CTIC.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=CTIC
RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search
DTCC: http://search2.dtcc.com/?q=Cell+Therapeutics%...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...ics%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://www.cticseattle.com
Alexa: http://www.alexa.com/siteinfo/http://www.cticseattle.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.cticseattle.com
http://www.pennystocktweets.com/stocks/profile/CTIC
##### last known share structure ~ source: otcmarkets.com
Market Value: $235,080,391 a/o Dec 11, 2013
Shares Outstanding: 129,878,669 a/o Oct 25, 2013
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
##### business description ~ source: otcmarkets.com
DD Notes ~ http://www.ddnotesmaker.com/CTIC


Scroll down for more posts ▼